Association between hepatitis B virus infection and metabolic syndrome: A retrospective cohort study in Shanghai, China

BMC Public Health

Volumn 14, Issue 1, 2014, Pages

  Zhou, Yanbing ^a,b   Cui, Yan ^b   Deng, Haiju ^b   Yu, Jinming ^c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Shanghai Center for Disease Control and Prevention   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CHINA; COHORT ANALYSIS; COMPLICATION; FEMALE; HEPATITIS B, CHRONIC; HUMAN; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; CHINA; COHORT STUDIES; FEMALE; HEPATITIS B, CHRONIC; HUMANS; INCIDENCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84902256764     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-14-516     Document Type: Article

References (39)

1. Association of the metabolic syndrome with vascular disease in an older Chinese population: Guangzhou Biobank Cohort Study. Lao XQ, Thomas GN, Jiang CQ, Zhang WS, Yin P, Adab P, Lam TH, Cheng KK, J Endocrinol Invest 2006 29 11 989 996 10.1007/BF03349212 17259796
2. Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? Stern MP, Williams K, Gonzalez-Villalpando C, Hunt KJ, Haffner SM, Diabetes Care 2004 27 11 2676 2681 10.2337/diacare.27.11.2676 15505004
3. Ten-year incidence of diabetes in older Australians: the Blue Mountains Eye Study. Cugati S, Wang JJ, Rochtchina E, Mitchell P, Med J Aust 2007 186 3 131 135 17309402
4. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel on Detection E, Adults ToHBCi, JAMA 2001 285 19 2486 2497 10.1001/jama.285.19.2486 11368702
5. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, Taskinen MR, Groop L, Diabetes Care 2001 24 4 683 689 10.2337/diacare.24.4.683 11315831
6. Syndrome X and mortality: a population-based study. Risk Factor and Life Expectancy Research Group. Trevisan M, Liu J, Bahsas FB, Menotti A, Am J Epidemiol 1998 148 10 958 966 10.1093/oxfordjournals.aje.a009572 9829867
7. The metabolic syndrome-a new worldwide definition. Alberti KGMM, Zimmet P, Shaw J, Lancet 2005 366 9491 1059 1062 10.1016/S0140-6736(05)67402-8 16182882
8. Obesity and the metabolic syndrome in children and adolescents. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S, N Engl J Med 2004 350 23 2362 2374 10.1056/NEJMoa031049 15175438
9. Mo H, National epidemiological investigation report of hepatitis B virus serology Beijing: People's Medical Publishing House 2011
10. Association of diabetes mellitus and chronic hepatitis C virus infection. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP, Hepatology 1999 29 2 328 333 10.1002/hep.510290235 9918906
11. Metabolic profiles in patients with chronic hepatitis C: a case-control study. Hsu CS, Liu CJ, Liu CH, Chen CL, Lai MY, Chen PJ, Chen DS, Kao JH, Hepatol Int 2008 2 2 250 257 10.1007/s12072-008-9064-3 19669312
12. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL, Ann Intern Med 2000 133 8 592 599 10.7326/0003-4819-133-8-200010170-00009 11033586
13. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G, Hepatology 2001 33 6 1358 1364 10.1053/jhep.2001.24432 11391523
14. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C. Liu CJ, Jeng YM, Chen PJ, Lai MY, Yang HC, Huang WL, Kao JH, Chen DS, Antivir Ther 2005 10 3 405 415 15918331
15. Hepatitis C virus infection and metabolic syndrome - a community-based study in an endemic area of Taiwan. Huang JF, Chuang WL, Yu ML, Yu SH, Huang CF, Huang CI, Yeh ML, Hsieh MH, Yang JF, Lin ZY, Chen SC, Dai CY, Chang WY, Kaohsiung J Med Sci 2009 25 6 299 305 10.1016/S1607-551X(09)70520-0 19560994
16. Chronic hepatitis B virus infection and dyslipidemia. Su TC, Lee YT, Cheng TJ, Chien HP, Wang JD, J Formos Med Assoc 2004 103 4 286 291 15175824
17. Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection. Huo TI, Wu JC, Lee PC, Tsay SH, Chang FY, Lee SD, J Clin Gastroenterol 2000 30 3 250 254 10.1097/00004836-200004000-00009 10777182
18. Increased frequency of HCV and HBV infection in type 2 diabetic patients. Sangiorgio L, Attardo T, Gangemi R, Rubino C, Barone M, Lunetta M, Diabetes Res Clin Pract 2000 48 2 147 151 10.1016/S0168-8227(99)00135-7 10802152
19. HBsAg carrier status and the association between gestational diabetes with increased serum ferritin concentration in Chinese women. Lao TT, Tse KY, Chan LY, Tam KF, Ho LF, Diabetes Care 2003 26 11 3011 3016 10.2337/diacare.26. 11.3011 14578232
20. A population-based study investigating the association between metabolic syndrome and hepatitis B/C infection (Keelung Community-based Integrated Screening study No. 10). Jan CF, Chen CJ, Chiu YH, Chen LS, Wu HM, Huang CC, Yen MF, Chen TH, Int J Obes (Lond) 2006 30 5 794 799 10.1038/sj.ijo.0803204 16404404
21. Association of metabolic syndrome and hepatitis B infection in a Chinese population. Luo B, Wang Y, Wang K, Clin Chim Acta 2007 380 1-2 238 240 17316590
22. Unexpected lower prevalence of HBsAg in diabetics than in controls. (A study on 2,465 patients). Bedarida G, D'Agostino F, Bianchi M, Susani G, Sangalli F, Fattorini A, Sterza G, Ric Clin Lab 1982 12 2 409 415 7111984
23. Lower plasma adiponectin is correlated to higher alanine aminotransferase independent of metabolic factors and hepatitis B virus carrier status. Lu JY, Su TC, Liu YH, Hsu HJ, Chen CL, Yang WS, Intern Med J 2007 37 6 365 371 10.1111/j.1445-5994.2007.01364.x 17535379
24. Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy. Lu JY, Chuang LM, Yang WS, Tai TY, Lai MY, Chen PJ, Kao JH, Lee CZ, Lee HS, Liver Int 2005 25 4 752 759 10.1111/j.1478-3231.2005.1007.x 15998426
25. Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study. Zhao J, Zhao Y, Wang H, Gu X, Ji J, Gao C, Nutr J 2011 10 49 10.1186/1475-2891-10-49 21569630
26. Association between metabolic syndrome and its individual components with viral hepatitis B. Jinjuvadia R, Liangpunsakul S, Am J Med Sci 2014 347 1 23 27 10.1097/MAJ.0b013e31828b25a5 23514672
27. Association between the hepatitis B and C viruses and metabolic diseases in patients stratified by age. Li WC, Lee YY, Chen IC, Sun C, Chiu FH, Chuang CH, Liver Int 2013 33 8 1194 1202 10.1111/liv.12224 23782533
28. Hepatitis B virus infection in patients with metabolic syndrome: A complicated relationship. Results of a population based study. Jarcuska P, Janicko M, Kruzliak P, Novak M, Veseliny E, Fedacko J, Senajova G, Drazilova S, Madarasova-Geckova A, Marekova M, Pella D, Siegfried L, Kristián P, Kolesárová E, HepaMeta Study Group, Eur J Intern Med 2014 25 3 286 291 10.1016/j.ejim.2014.01.006 24445023
29. Impact of hepatitis B virus infection on metabolic profiles and modifying factors. Hsu CS, Liu CH, Wang CC, Tseng TC, Liu CJ, Chen CL, Chen PJ, Chen DS, Kao JH, J Viral Hepat 2012 19 2 48 e57 10.1111/j.1365-2893.2011.01535.x 22239526
30. Obesity and hepatitis B infection are associated with increased risk of metabolic syndrome in university freshmen. Yen SL, Chiu TY, Lin YC, Lee YC, Lee LT, Huang KC, Int J Obes (Lond) 2008 32 3 474 480 10.1038/sj.ijo.0803753 17955029
31. Insulin resistance: syndrome or tendency? Godsland IF, Stevenson JC, The Lancet 1995 346 8967 100 103 10.1016/S0140-6736(95)92118-4
32. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. Liu CJ, Chen PJ, Jeng YM, Huang WL, Yang WS, Lai MY, Kao JH, Chen DS, J Hepatol 2005 43 2 235 242 10.1016/j.jhep.2005.02.044 15964656
33. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Hsu CS, Liu CJ, Liu CH, Wang CC, Chen CL, Lai MY, Chen PJ, Kao JH, Chen DS, Liver Int 2008 28 2 271 277 18028320
34. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P, Gastroenterology 2008 134 2 416 423 10.1053/j.gastro.2007.11.010 18164296
35. Global control of hepatitis B virus infection. Kao JH, Chen DS, Lancet Infect Dis 2002 2 7 395 403 10.1016/S1473-3099(02)00315-8 12127351
36. Prevalence of the metabolic syndrome in Pudong New Area of Shanghai using three proposed definitions among Chinese adults. Xu WH, Ruan XN, Fu XJ, Zhu QL, Zhang H, Bai Y, Wu HY, Zhou Y, Qiu H, Sun Q, Jiang QW, Yang LM, Gu JJ, Zhao GM, BMC public health 2010 10 246 10.1186/1471-2458-10-246 20459855
37. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. Ford ES, Giles WH, Dietz WH, JAMA 2002 287 3 356 359 10.1001/jama.287.3.356 11790215
38. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB, Arch Intern Med 2003 163 4 427 436 10.1001/archinte.163.4.427 12588201
39. Impaired lung function is associated with obesity and metabolic syndrome in adults. Lin WY, Yao CA, Wang HC, Huang KC, Obesity (Silver Spring) 2006 14 9 1654 1661 10.1038/oby.2006.190 17030977